This is unpublished

Mary-Elizabeth M.

she, her, hers
Physician & Research Faculty
Associate Professor, Division of Hematology and Oncology, University of Washington
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Center
Sites of Practice
Fred Hutchinson Cancer Center - South Lake Union

education, training, board certifications

  • M.D., Stanford University
  • Residency in Internal Medicine, University of California, San Francisco
  • Fellowship in Hematology/Oncology, Stanford University
  • Internal Medicine, American Board of Internal Medicine
  • Hematology, American Board of Internal Medicine
  • Oncology, American Board of Internal Medicine

clinical expertise

  • Acute lymphoblastic leukemia
  • Acute myeloid leukemia
  • Leukemia
  • Myelodysplastic syndrome
  • Myelomonocytic leukemia
  • Myeloproliferative neoplasms


University of Washington

Fred Hutchinson Cancer Center - Faculty & Labs

Fred Hutchinson Cancer Center - Provider


clinical and/or research interests

Dr. Mary-Elizabeth Percival develops early-phase clinical trials for patients with acute myelogenous leukemia (AML), specifically testing new drugs and new combinations of drugs. Additionally, she performs epidemiological research, using data from patients with AML treated at UW and beyond.